title: The single unit transfusion in post partum hemorrhage: A new perspective.
abstract: Every year, about 210 million women become pregnant. Postpartum hemorrhage (PPH) is one of the major complications of pregnancy, accounting for 14 million cases annually. Of these, it is estimated that around 140,000 women die, resulting in a case fatality rate of 1%. PPH is defined by WHO as a blood loss > or = 500 mls. Most instances of PPH occur suddenly and without warning even in women without any of the known risks for this condition. If women do not receive timely medical treatment, as is often the case in many parts of the world, death can occur within two hours. The chance of receiving a safe blood transfusion as part of the therapy for PPH varies enormously from country to country, depending on whether a safe blood transfusion program has been set up as a part of the national health policy. The increasing realization of the potential deleterious effects of blood transfusion, including exposure to HIV and other viral agents, has changed the practices that were previously acceptable for the transfusion of blood, as has the recent recognition of specific patients who will benefit from a single unit of blood. In countries with limited resources, where a majority of women have anemia at the onset of their pregnancies, the slightest deviation from normality during labor and/or delivery leading to excessive hemorrhage can put a women's life at risk. In these instances, the patient needs urgent resuscitation, stabilization and transfer to a nearby center. Available blood, preferably typed cross matched and screened for infections, should be given until the patient receives specific treatment. This is especially true in bled- out obstetrics patients, where one unit may make the difference between a near death state and the possibility of slow recovery and survival.
authors.affiliation: Epsom and St. Helier University Hospitals, Epsom, Surrey, United Kingdom. namav@aol.com
authors.forename: Vivek
authors.initials: V
authors.lastname: Nama
authors.forename: Mahantesh
authors.initials: M
authors.lastname: Karoshi
authors.forename: V
authors.initials: V
authors.lastname: Kakumani
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000628:therapy; D001793:Blood Preservation / Q000379:methods*; D019049:Developed Countries; D003906:Developing Countries; D005260:Female; D006801:Humans; D008429:Maternal Welfare; D011181:Postnatal Care / Q000379:methods*; D006473:Postpartum Hemorrhage / Q000628:therapy*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D011256:Pregnancy Outcome